On 30 October 2026 the Centers for Medicare and Medicaid Services (CMS) finalised a rule that tightens federal oversight of organ procurement organizations, the groups that connect donor hospitals with transplant programs. These organizations secure authorisation for donations, recover organs and coordinate their safe and timely delivery to transplant programs. The agency says the rule is meant to help more donated organs reach patients at a time when need still outruns supply. The Department of Health and Human Services (HHS) reports that more than 49,000 transplants were performed in the United States in 2025, while more than 100,000 Americans are waiting for a lifesaving transplant.
What the Rule Changes
The central change is accountability. The rule defines unsound medical practices, which clarifies when CMS may use its existing authority to immediately decertify a noncompliant organization to protect patients. It also spells out the circumstances under which CMS may decertify an organization, and it codifies a process for discretionary review by the CMS Administrator of hearing officer decisions, with updated appeals timeframes. Organizations also get clearer guidance on spotting, investigating and preventing adverse events. On staffing, an organization's medical director must hold a licence in at least one state or territory the organization serves. The rule also removes a requirement that had limited certification to organizations recertified between 2002 and 2005.
The rule also changes how organizations hand over territory and how their performance is scored. High-performing organizations can compete for multiple donation service areas. When one organization takes over from another, the outgoing organization must cooperate with the incoming one, and the incoming organization must submit a transition plan with progress updates so donation work in the area is not interrupted. On measurement, a donor whose pancreas is procured only for islet cell research still counts toward the organization's donation rate, but pancreata used only for islet cell research no longer count toward the transplantation rate unless transplanted. Organizations must now track and record what happens to organs sent for research. HHS says this keeps transplant performance scores tied to organs actually transplanted into patients.
Background: The 2020 Rule and the New Timeline
The new rule builds on a 2020 rule that set transparent performance measures for organizations and opened low-performing service areas to competition. HHS says that since that rule was issued, organ donations have increased by 36 percent nationwide, transplants have increased by 30 percent, and the number of lowest-performing organizations continues to decline. Becker's Hospital Review reports that the agency first proposed the latest rule in January 2026, that it takes effect 60 days after its Federal Register publication on 3 November 2026, and that CMS estimates it will cost 16.5 million dollars in the first year and 7.9 million dollars a year after that. The nation's 54 organizations currently serve 55 donation service areas, according to Becker's. The same report notes what CMS left out: proposed definitions for medically complex organs and related tracking requirements were dropped after commenters were split, broader staff licensure was dropped after warnings about workforce strain, and comments on automated hospital referrals may inform future rulemaking instead.
Why This Matters for Healthcare Organizations
For donor hospitals and transplant programs, the practical effects sit in handovers and paperwork rather than in day-to-day clinical decisions. A change of organization in a service area should now come with a transition plan and progress updates, which gives hospitals a clearer point of contact during the switch. The research-organ documentation rule means hospitals and organizations need a shared record of where research organs go, not just where procured organs go. The scoring change also matters for how organizations are judged: a research-only pancreas can no longer lift a transplantation rate, so performance conversations will rest more on organs transplanted into patients. Hospitals that refer potential donors should expect the same donation conversations, but with firmer expectations behind them on adverse event handling and on cooperation during transitions.
Analysis: Two Levers, and a Test Still to Come
This rule pulls two levers at once: it makes it easier to remove a poor performer, and it makes it easier for a strong performer to take on more territory. That combination only works if the measurement underneath it is trusted, which is why the research-pancreas change matters more than it first appears. Counting a research organ as a transplant flattered a score without helping a patient on the waiting list. Removing that credit tightens the link between the score and the outcome patients care about. The rule does not create donors, and it does not shorten the waiting list by itself. Its test will be quieter: whether handovers run without gaps, whether decertification is used when it is warranted, and whether the organizations that expand into new areas keep donation rates up once they get there.
Hospitals and clinics reviewing how referrals, coordination and patient communication work across partner organizations can explore MedClinicX's AI patient portal, see how after-hours calls are handled on our AI medical receptionist page, or explore the demos and request a quote for their own practice.
Sources and References
- U.S. Department of Health and Human Services — CMS Finalizes Rule to Help More Organs Reach Patients and Strengthen Accountability for Organ Procurement Organizations, 30 October 2026: https://www.hhs.gov/press-room/cms-finalizes-rule-organ-procurement-organizations-transplant-accountability.html
- Becker's Hospital Review — CMS finalizes organ procurement organization oversight rule: 7 notes, 30 October 2026: https://www.beckershospitalreview.com/quality/patient-safety-outcomes/cms-finalizes-organ-procurement-organization-oversight-rule-7-notes/
Reporting based on the sources above, accessed 1 November 2026. The HHS announcement and the Becker's report were read directly in full and cross-checked against each other. MedClinicX did not conduct original reporting or interviews for this article. This article is for information only and is not medical advice. Corrections: contact us via https://medclinicx.com/contact